Acute pulmonary embolism advances in treatment.

摘要: Recent advances in interventional cardiology, pharmacotherapeutics and modern surgical management tertiary cardiac care centers have tremendously improved the present treatment of Pulmonary Embolism (PE). CT pulmonary angiography (CTPA), nuclear lung scan (V/Q scan), D-dimer test echocardiography revolutionized diagnostic methodology risk assessment criteria. Cardiogenic shock or systolic hypotension (BP < 90 mmHg) presence right ventricular dysfunction (or failure) are two principal criteria which govern severity embolism. While all patients embolism require anticoagulation, systemic thrombolytic therapy is mainstay initial massive submassive When thrombolysis contraindicated has failed, urgent embolectomy catheter may be life saving procedures severe